Recurrence of ANCA-Associated Vasculitis After Kidney Transplantation in a Patient With Pulmonary Tuberculosis: A Case Report.

Transplant ProcJul 29, 2026 (epub)

Phillipe Guilherme do Rego Silva, Marclebio Manuel Coelho Dourado, Maria Ruth Padilha de Medeiros et al.

✦ AI-curated · Sources linked

Case in brief

A 28-year-old male kidney transplant recipient with a history of granulomatosis with polyangiitis (GPA) developed pulmonary tuberculosis six years post-transplant. Following antituberculous therapy, he experienced allograft dysfunction and elevated serum C-ANCA levels. A kidney biopsy confirmed recurrent GPA. Treatment with corticosteroids, cyclophosphamide, and rituximab improved renal function while managing tuberculosis effectively.

Diagnostic / clinical pearl

Clinicians should consider the recurrence of ANCA-associated vasculitis in kidney transplant recipients presenting with allograft dysfunction, especially when infections and immunosuppressive changes are present.

Why it matters

This case underscores the importance of individualized management strategies in transplant patients, particularly when balancing the treatment of infections and the risk of vasculitis recurrence.

Source

Published in Transplant Proc. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Nephrology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.